A long-term follow up focussing on the alterations in gut microbiota and metabolic fluctuations could help us understand the pathogenesis better
NPJ Parkinsons Dis
J.MavroudisI.BaloyannisI
doi: 10.1186/s12967-025-06635-8 50
Disclosures: Khalid Aloum: Nothing to Disclose, Amr Dokmak: Nothing to Disclose, Wendy Tatiana Garzon-Siatoya: Nothing to Disclose, Abdellatif Ismail: Nothing to Disclose, Camelia Ciobanu: Nothing to Disclose, Jeeva Jaganathan: Nothing to Disclose, Praneeth Bandaru: Nothing to Disclose, Ali Wakil: Nothing to Disclose, Arnold Nongmoh Forlemu: Nothing to Disclose, Vijay Bhaskar Reddy Gayam: Nothing to Disclose, Vikash Kumar: Nothing to Disclose, Raissa Nana Sede Mbakop: Nothing to Disclose, Lisnaldy Ramirez: Nothing to Disclose, Manasa Ginjupalli: Nothing to Disclose, Denzil Etienne: Nothing to Disclose, Nithan Narendra: Nothing to Disclose, Madhavi Reddy: Nothing to Disclose 1055 UTILIZING FIB-4 AND TRANSIENT ELASTOGRAPHY TO DIAGNOSE STEATOTIC LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES: QUALITY IMPROVEMENT PROJECT AT A VETERANS AFFAIRS RESIDENT CLINIC Nimmy Thomas 1 Christina Stull 1 Holli Sadler 2 , 1 UT Austin Dell Medical School, 2 Central Texas Veterans Affairs Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality
